tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Marie Thibault, 163 are a BUY (94.22%), 10 are a HOLD (5.78%).
Analyst Marie Thibault, currently employed at BTIG, carries an average stock price target met ratio of 42.79% that have a potential upside of 30.89% achieved within 109 days.
Marie Thibault’s has documented 341 price targets and ratings displayed on 26 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ATRC, AtriCure at 18-Feb-2026.
Analyst best performing recommendations are on STIM (NEURONETICS).
The best stock recommendation documented was for STIM (NEURONETICS) at 1/21/2021. The price target of $21 was fulfilled within 1 day with a profit of $2.58 (14.01%) receiving and performance score of 140.07.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 17-Dec-2018
$142
$29.79 (26.55%)
$169
21 days ago
(02-Feb-2026)
18/27 (66.67%)
$32.59 (29.79%)
511
Buy Since 06-Jun-2019
$140
$27.79 (24.77%)
$160
1 months ago
(23-Jan-2026)
12/16 (75%)
$32.58 (30.33%)
485
Buy Since 19-Sep-2024
$135
$22.79 (20.31%)
$150
1 months ago
(23-Jan-2026)
2/5 (40%)
$27.58 (25.67%)
143
Buy Since 27-Jun-2018
$125
$12.79 (11.40%)
$154
1 months ago
(23-Jan-2026)
3/6 (50%)
$17.58 (16.37%)
595
Buy Since 18-Jul-2018
$138
$25.79 (22.98%)
$142
1 months ago
(23-Jan-2026)
9/15 (60%)
$30.58 (28.47%)
310
Which stock is Marie Thibault is most bullish on?
Which stock is Marie Thibault is most reserved on?
What Year was the first public recommendation made by Marie Thibault?
